Emulsion Formulation Optimization and Characterization of Spray-dried κ-carrageenan Microparticles for the Encapsulation of CoQ10

Overview

Journal Food Sci Biotechnol

Specialty Biotechnology

Date 2018 Sep 29

PMID 30263486

Citations 3

Authors

Sook Wah Chan

Hamed Mirhosseini

Farah Saleena Taip

Tau Chuan Ling

Imededdine Arbi Nehdi

Chin Ping Tan

Affiliations

Soon will be listed here.

Abstract

The present study is aimed to prepare κ-carrageenan microparticles for the encapsulation of model drug, coenzyme Q10 (CoQ10). A face-centered central composite design was employed to study the effects of three different formulation variables (κ-carrageenan, emulsifier, and oil). The powder yield was found inversely affected by the κ-carrageenan and oil concentration. The encapsulation efficiency was maximized in the region of the middle level κ-carrageenan concentration, the high level emulsifier concentration, and the low level oil concentration. The emulsifier concentration was the most influential variable on the particle size of powder. The optimal formulation was reported as 0.91% (w/v) κ-carrageenan concentration, 0.64% (w/v) emulsifier, and 1.0% (w/w) oil. Both differential scanning colorimeter and X-ray diffraction analyses proved that incorporation of CoQ10 into κ- carrageenan microcapsules resulted in amorphous powder with significantly (<0.05) higher water solubility compared to pure CoQ10 and physical mixture in the crystalline form.

Citing Articles

Natural Polymers as Carriers for Encapsulation of Volatile Oils: Applications and Perspectives in Food Products.

Tita O, Constantinescu M, Rusu L, Tita M Polymers (Basel). 2024; 16(8).

PMID: 38674945 PMC: 11054478. DOI: 10.3390/polym16081026.

Contemporary Aspects of Designing Marine Polysaccharide Microparticles as Drug Carriers for Biomedical Application.

Lukova P, Katsarov P Pharmaceutics. 2023; 15(8).

PMID: 37631340 PMC: 10458623. DOI: 10.3390/pharmaceutics15082126.

Carrageenan: Drug Delivery Systems and Other Biomedical Applications.

Pacheco-Quito E, Ruiz-Caro R, Veiga M Mar Drugs. 2020; 18(11).

PMID: 33238488 PMC: 7700686. DOI: 10.3390/md18110583.

References

Yoo S, Song Y, Chang P, Lee H . Microencapsulation of alpha-tocopherol using sodium alginate and its controlled release properties. Int J Biol Macromol. 2006; 38(1):25-30. DOI: 10.1016/j.ijbiomac.2005.12.013. View

Sankalia M, Mashru R, Sankalia J, Sutariya V . Stability improvement of alpha-amylase entrapped in kappa-carrageenan beads: physicochemical characterization and optimization using composite index. Int J Pharm. 2006; 312(1-2):1-14. DOI: 10.1016/j.ijpharm.2005.11.048. View

Bhandari K, Newa M, Kim J, Yoo B, Woo J, Lyoo W . Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution. Biol Pharm Bull. 2007; 30(6):1171-6. DOI: 10.1248/bpb.30.1171. View

Lunetta S, Roman M . Determination of coenzyme Q10 content in raw materials and dietary supplements by high-performance liquid chromatography-UV: collaborative study. J AOAC Int. 2008; 91(4):702-8. PMC: 2586118. View

Piao H, Ouyang M, Xia D, Quan P, Xiao W, Song Y . In vitro-in vivo study of CoQ10-loaded lipid nanoparticles in comparison with nanocrystals. Int J Pharm. 2011; 419(1-2):255-9. DOI: 10.1016/j.ijpharm.2011.07.016. View

Hansen T, Holm P, Schultz K . Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid. Int J Pharm. 2004; 287(1-2):55-66. DOI: 10.1016/j.ijpharm.2004.08.014. View

Nekkanti V, Muniyappan T, Karatgi P, Hari M, Marella S, Pillai R . Spray-drying process optimization for manufacture of drug-cyclodextrin complex powder using design of experiments. Drug Dev Ind Pharm. 2009; 35(10):1219-29. DOI: 10.1080/03639040902882264. View

Piyakulawat P, Praphairaksit N, Chantarasiri N, Muangsin N . Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac. AAPS PharmSciTech. 2008; 8(4):E97. PMC: 2750683. DOI: 10.1208/pt0804097. View

Lee W, Tsai T . Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application. Int J Pharm. 2010; 395(1-2):78-83. DOI: 10.1016/j.ijpharm.2010.05.006. View

10.

Nazzal S, Smalyukh I, Lavrentovich O, Khan M . Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm. 2002; 235(1-2):247-65. DOI: 10.1016/s0378-5173(02)00003-0. View

11.

Seo D, Kang M, Sohn Y, Lee J . Self-microemulsifying formulation-based oral solution of coenzyme Q10. Yakugaku Zasshi. 2009; 129(12):1559-63. DOI: 10.1248/yakushi.129.1559. View

12.

Burey P, Bhandari B, Howes T, Gidley M . Hydrocolloid gel particles: formation, characterization, and application. Crit Rev Food Sci Nutr. 2008; 48(5):361-77. DOI: 10.1080/10408390701347801. View

13.

Balakrishnan P, Lee B, Oh D, Kim J, Lee Y, Kim D . Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm. 2009; 374(1-2):66-72. DOI: 10.1016/j.ijpharm.2009.03.008. View

14.

Hatanaka J, Kimura Y, Lai-Fu Z, Onoue S, Yamada S . Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations. Int J Pharm. 2008; 363(1-2):112-7. DOI: 10.1016/j.ijpharm.2008.07.019. View

15.

Bhagavan H, Chopra R, Craft N, Chitchumroonchokchai C, Failla M . Assessment of coenzyme Q10 absorption using an in vitro digestion-Caco-2 cell model. Int J Pharm. 2006; 333(1-2):112-7. DOI: 10.1016/j.ijpharm.2006.10.007. View

16.

Zhang T, Murowchick J, Youan B . Optimization of formulation variables affecting spray-dried oily core nanocapsules by response surface methodology. J Pharm Sci. 2010; 100(3):1031-44. DOI: 10.1002/jps.22341. View